No products
View larger AOB16508
CAS 1616428-23-9
Chemical Name: CG806; CG026806; 1-(3-Fluoro-4-(7-(5-methyl-1H-imidazol-2-yl)-1-oxoisoindolin-4-yl)phenyl)-3-(2,4,6-trifluorophenyl)urea
1000 Items
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $109.65 | Total: $548.25 |
| 1 | 10 | $92.88 | Total: $928.80 |
| 1 | 25 | $78.69 | Total: $1,967.25 |
| 1 | 50 | $67.08 | Total: $3,354.00 |
| 1 | 100 | $58.05 | Total: $5,805.00 |
| Molecular Formula | C25H17F4N5O2 |
| Molecular Weight | 495.43 |
| CAS Numbers | 1616428-23-9 |
| Storage Condition | 0°C (short term), -20°C (long term), desiccated |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| Synonym | CG806; CG026806 |
| IUPAC/Chemical Name | 1-(3-Fluoro-4-(7-(5-methyl-1H-imidazol-2-yl)-1-oxoisoindolin-4-yl)phenyl)-3-(2,4,6-trifluorophenyl)urea |
| SMILES Code | O=C(NC1=C(F)C=C(F)C=C1F)NC2=CC(F)=C(C(C=CC(C3=NC(C)=CN3)=C45)=C5CNC4=O)C=C2 |
| References | 1) Ekaterina Kim MS, et al. CG-806, a First-in-Class Pan-FLT3/Pan-BTK Inhibitor, Exhibits Broad Signaling Inhibition in Chronic Lymphocytic Leukemia Cells. bloodjournal Blood blood (2019). 134 (Supplement_1) : 3051. 2) Abstract 44: CG′806, a first-in-class FLT3/BTK inhibitor, exhibits potent activity against AML patient samples with mutant or wild type FLT3, as well as other hematologic malignancy subtypes |
Novel potent pan-FLT3/pan-BTK inhibitor, inhibiting wild type and many of the clinically relevant mutant forms of FLT3 at low nanomolar concentrations, targeting FLT3 and clusters of kinases operative in acute myeloid leukemia